Pedro Lichtinger, Director at Gemphire Therapeutics Inc. (GEMP), bought 49,274 shares at $10.00 ($364K) on 2016-08-10, disclosed to the SEC on 2016-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.71 | 39,274 | $264K | 72.5% |
| 2 | $10.00 | 10,000 | $100K | 27.5% |
| Total | $7.38 avg | 49,274 | $364K | 100% |
| Filing → |
| OPTR | SELL | 2013-04-10 | $2.2M | — | Filing → |
| OPTR | BUY | 2012-11-19 | $100K | — | Filing → |
| BTX | BUY | 2012-04-12 | $25K | — | Filing → |